On Monday, Shares of Frontier Communications Corp (NASDAQ:FTR), gained 2.59% to $4.76.
Frontier Communications Corporation, declared the appointment of Peter T. DePasquale as vice president of communications and corporate affairs.
DePasquale will be based at Frontier’s corporate headquarters in Norwalk, Connecticut, and will report to Executive Vice President, General Counsel and Secretary Mark Nielsen. DePasquale will be responsible for developing and executing a corporate communications and engagement strategy nationwide.
An practiced communicator, DePasquale has a breadth of expertise in external affairs and public engagement. DePasquale joins Frontier from Praxair, Inc., a global supplier of industrial gases and high performance surface coatings, where he served as director of Government and External Relations and was responsible for the company’s domestic public policy communications and positioning.
Commenting on the appointment, Nielsen noted, “We are happy to have Pete join our corporate communications team. As Frontier Communications continues to grow, our company’s ability to proactively engage with the public through the press and social media will be critical. Pete’s positive leadership and expertise are a great addition.”
Frontier Communications Corporation, a communications company, provides regulated and unregulated voice, data, and video services to residential, business, and wholesale customers in the United States.
Shares of Gilead Sciences, Inc. (NASDAQ:GILD), inclined 1.21% to $103.81, during its last trading session.
Gilead Sciences, declared that its Phase 3 Study 115 evaluating Zydelig (idelalisib) added to standard therapy in formerly-treated chronic lymphocytic leukemia (CLL) patients will be unblinded early. The DMC recommendation is based upon a predefined interim analysis indicating a statistically noteworthy benefit in efficacy for progression-free survival (PFS) and overall survival (OS) in patients receiving Zydelig plus bendamustine and rituximab, contrast to those receiving only bendamustine and rituximab. The safety profile of Zydelig was compriseent with preceding studies. Detailed results from this study will be presented during a late-breaking abstracts session (#LBA-5) at the Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida taking place December 5-8.
Zydelig is approved in the United States in combination with rituximab for patients with relapsed CLL for whom rituximab alone would be considered appropriate therapy due to comorbidities.
“The clinical benefit observed in this Phase 3 study adds to the body of evidence demonstrating the potential of Zydelig-containing treatment regimens for patients with formerly treated CLL,” said Norbert W. Bischofberger, PhD, Gilead’s Executive Vice President, Research and Development and Chief Scientific Officer. “We look forward to sharing the detailed scientific data with the hematology community at the forthcoming ASH meeting.”
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific.
Finally, Shares of Electronic Arts Inc. (NASDAQ:EA), ended its last trade with -2.72% loss, and closed at $67.99.
Electronic Arts, declared EA SPORTS™ UFC 2 will launch this Spring, featuring UFC bantamweight champion “Rowdy” Ronda Rousey as the game’s global lead cover athlete. Rousey, the undefeated UFC champion (12-0), is the most dominant and recognized fighter in the world. Hear what Rousey thinks about the cover and get a first look of the champ in the virtual Octagon® here.
“EA Sports is a cultural barometer to know what’s going on in sports at the moment,” said Rousey. “As a gamer myself, it’s pretty surreal to be on the cover of the game and to have a woman on the cover of a UFC game shows a lot of progress. I’m really happy to be involved with it.”
EA SPORTS UFC 2 takes the franchise’s stunning character likeness and animation to another level, adds an all-new Knockout Physics System and authentic game play features, and introduces the biggest ever roster of real-world fighters in a MMA game who will step back into the Octagon on Xbox One and PlayStation4.
“Like any champion fighter going into their next fight, we listened to our corner – in our case, the fans – and took a detailed look at everything we can do to take the fight game to a whole new level,” said Creative Director Brian Hayes. “We’re doing that by introducing innovative gameplay features, delivering a game mode for every fighter regardless of their style of play, and adding assistful tools so fans can master MMA, all while producing the jaw-dropping visuals that fans expect.”
Electronic Arts Inc. develops, markets, publishes, and distributes game software content and online services for video game consoles, Internet-connected consoles, personal computers, mobile phones, and tablets worldwide. The company operates through EA Studios, EA Mobile, and Maxis divisions.